EMJ GOLD - European Medical Journal

Continue

Pharma News, Views & Analysis

Filter Advertise With Us

FDA fast-tracks brelovitug for treatment of chronic hepatitis D

The drug has been granted Breakthrough Therapy designation by the FDA for the treatment of chronic hepatitis delta (CHD).
Handshake on a green background

LEO Pharma to market Junshi Biosciences's toripalimab

Shanghai-based Junshi Biosciences has announced a partnership with Denmark’s LEO Pharma to distribute and commercialise the drug in Europe.
Gold crown on blue background

The HBA crowns its '2025 Woman of the Year'

The Healthcare Businesswomen’s Association (HBA) has announced its 2025 winners as Reshema Kemps-Polanco, Executive Vice President and Chief Commercial Officer, Novartis US.

Robeauté’s microbot brain technology secures $28m

The company’s microbot technology holds huge potential for exploring and delivering treatments to the brain.
Checklist

Major changes to product information leaflets to hit Europe

The European pharma sector is on the brink of regulatory and operational updates with new papers from pharmaceutical associations 
Illustration of a heart with a monitor

Heart failure drug market to reach $33.7bn by 2032

New analysis from GlobalData spans the growth of the heart failure market across seven major markets including the US, Europe and Japan. 

Needle-free vaccine technology wins $3.7m in funding from CEPI

Micron Biomedical, an Atlanta-based life sciences company, has received funding for its technology that could improve vaccine access.
Handshake on blue background

Vertex strikes deal for Orna Therapeutics' LNP technology

The deal is set to help Vertex’s development of next-generation gene editing therapies for sickle cell disease and beta-thalassemia.